Global COVID-19 Recombinant Protein Vaccine Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global COVID-19 Recombinant Protein Vaccine Market Size 2022-2028

2.1.2 COVID-19 Recombinant Protein Vaccine Market Size CAGR by Region

2.2 COVID-19 Recombinant Protein Vaccine Segment by Type

2.2.1 Being Developed

2.2.2 Preclinical

2.2.3 Clinical I

2.2.4 Clinical II

2.3 COVID-19 Recombinant Protein Vaccine Market Size by Type

2.3.1 Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2022-2028)

2.3.2 Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate by Type (2022-2028)

2.4 COVID-19 Recombinant Protein Vaccine Segment by Application

2.4.1 Pharmaceutical And Biotechnology Companies

2.4.2 Hospital

2.4.3 Academic And Research Organizations

2.4.4 Other

2.5 COVID-19 Recombinant Protein Vaccine Market Size by Application

2.5.1 Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2022-2028)

2.5.2 Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate by Application (2022-2028)

3 COVID-19 Recombinant Protein Vaccine Key Players

3.1 Date of Key Players Enter into COVID-19 Recombinant Protein Vaccine

3.2 Key Players COVID-19 Recombinant Protein Vaccine Product Offered

3.3 Key Players COVID-19 Recombinant Protein Vaccine Funding/Investment Analysis

3.4 Funding/Investment

3.4.1 Funding/Investment by Regions

3.4.2 Funding/Investment by End-Industry

3.5 Key Players COVID-19 Recombinant Protein Vaccine Valuation & Market Capitalization

3.6 Key Players Mergers & Acquisitions, Expansion Plans

3.7 Market Ranking

3.8 New Product/Technology Launches

3.9 Partnerships, Agreements, and Collaborations

3.10 Mergers and Acquisitions

4 COVID-19 Recombinant Protein Vaccine by Regions

4.1 COVID-19 Recombinant Protein Vaccine Market Size by Regions (2022-2028)

4.2 United States COVID-19 Recombinant Protein Vaccine Market Size Growth (2022-2028)

4.3 China COVID-19 Recombinant Protein Vaccine Market Size Growth (2022-2028)

4.4 Europe COVID-19 Recombinant Protein Vaccine Market Size Growth (2022-2028)

4.5 Rest of World COVID-19 Recombinant Protein Vaccine Market Size Growth (2022-2028)

5 United States

5.1 United States COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028)

5.2 United States COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028)

6 China

6.1 China COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028)

6.2 China COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028)

7 Europe

7.1 Europe COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028)

7.2 Europe COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028)

8 Rest of World

8.1 Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028)

8.2 Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028)

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Key Investors in COVID-19 Recombinant Protein Vaccine

10.1 Company A

10.1.1 Company A Company Details

10.1.2 Company Description

10.1.3 Companies Invested by Company A

10.1.4 Company A Key Development and Market Layout

10.2 Company B

10.2.1 Company B Company Details

10.2.2 Company Description

10.2.3 Companies Invested by Company B

10.2.4 Company B Key Development and Market Layout

10.3 Company C

10.3.1 Company C Company Details

10.3.2 Company Description

10.3.3 Companies Invested by Company C

10.3.4 Company C Key Development and Market Layout

10.4 Company D

10.5 ……

11 Key Players Analysis

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK COVID-19 Recombinant Protein Vaccine Product Offered

11.1.3 GSK COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

11.1.4 GSK Main Business Overview

11.1.5 GSK News

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product Offered

11.2.3 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

11.2.4 Johnson & Johnson Main Business Overview

11.2.5 Johnson & Johnson News

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi COVID-19 Recombinant Protein Vaccine Product Offered

11.3.3 Sanofi COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

11.3.4 Sanofi Main Business Overview

11.3.5 Sanofi News

11.4 Novavax

11.4.1 Novavax Company Details

11.4.2 Novavax COVID-19 Recombinant Protein Vaccine Product Offered

11.4.3 Novavax COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

11.4.4 Novavax Main Business Overview

11.4.5 Novavax News

11.5 Pukang Biologic Technology

11.5.1 Pukang Biologic Technology Company Details

11.5.2 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product Offered

11.5.3 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

11.5.4 Pukang Biologic Technology Main Business Overview

11.5.5 Pukang Biologic Technology News

11.6 Clover Biopharmaceuticals

11.6.1 Clover Biopharmaceuticals Company Details

11.6.2 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product Offered

11.6.3 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

11.6.4 Clover Biopharmaceuticals Main Business Overview

11.6.5 Clover Biopharmaceuticals News

11.7 Suzhou Yuzhibo Biotechnology

11.7.1 Suzhou Yuzhibo Biotechnology Company Details

11.7.2 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product Offered

11.7.3 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

11.7.4 Suzhou Yuzhibo Biotechnology Main Business Overview

11.7.5 Suzhou Yuzhibo Biotechnology News

...

12 Research Findings and Conclusion

Table 1. COVID-19 Recombinant Protein Vaccine Market Size CAGR by Region (2022-2028) ($ Millions)

Table 2. Major Players of Being Developed

Table 3. Major Players of Preclinical

Table 4. Major Players of Clinical I

Table 5. Major Players of Clinical II

Table 6. Global COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 7. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2022-2028)

Table 8. Global COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 9. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2022-2028)

Table 10. Date of Global Key Players Enter into COVID-19 Recombinant Protein Vaccine Market

Table 11. Global Key Players COVID-19 Recombinant Protein Vaccine Product Offered

Table 12. Key Players COVID-19 Recombinant Protein Vaccine Funding/Investment ($ Millions)

Table 13. Funding/Investment by Regions

Table 14. Funding/Investment by End Industry

Table 15. Key Players COVID-19 Recombinant Protein Vaccine Valuation & Market Capitalization ($ Millions)

Table 16. Key Players Mergers & Acquisitions, Expansion Plans

Table 17. COVID-19 Recombinant Protein Vaccine New Product/Technology Launches

Table 18. COVID-19 Recombinant Protein Vaccine Industry Partnerships, Agreements, and Collaborations

Table 19. COVID-19 Recombinant Protein Vaccine Industry Mergers and Acquisitions

Table 20. Global COVID-19 Recombinant Protein Vaccine Market Size by Regions 2022-2028 ($ Millions)

Table 21. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions 2022-2028

Table 22. United States COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 23. United States COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2022-2028)

Table 24. United States COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 25. United States COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2022-2028)

Table 26. China COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 27. China COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2022-2028)

Table 28. China COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 29. China COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2022-2028)

Table 30. Europe COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 31. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2022-2028)

Table 32. Europe COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 33. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2022-2028)

Table 34. Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Type (2022-2028) ($ Millions)

Table 35. Rest of World COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2022-2028)

Table 36. Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Application (2022-2028) ($ Millions)

Table 37. Rest of World COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2022-2028)

Table 38. Key Market Drivers & Growth Opportunities of COVID-19 Recombinant Protein Vaccine

Table 39. Key Market Challenges & Risks of COVID-19 Recombinant Protein Vaccine

Table 40. Key Industry Trends of COVID-19 Recombinant Protein Vaccine

Table 41. Company A Company Details

Table 42. Companies Invested by Company A

Table 43. Company A Key Development and Market Layout

Table 44. Company B Company Details

Table 45. Companies Invested by Company B

Table 46. Company B Key Development and Market Layout

Table 47. Company C Company Details

Table 48. Companies Invested by Company C

Table 49. Company C Key Development and Market Layout

Table 50. Company C Company Details

Table 51. Companies Invested by Company C

Table 52. Company C Key Development and Market Layout

Table 53. GSK Basic Information, Head Office, Major Market Areas and Its Competitors

Table 54. GSK COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

Table 55. Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors

Table 56. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

Table 57. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors

Table 58. Sanofi COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

Table 59. Novavax Basic Information, Head Office, Major Market Areas and Its Competitors

Table 60. Novavax COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

Table 61. Pukang Biologic Technology Basic Information, Head Office, Major Market Areas and Its Competitors

Table 62. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

Table 63. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors

Table 64. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

Table 65. Suzhou Yuzhibo Biotechnology Basic Information, Head Office, Major Market Areas and Its Competitors

Table 66. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Market Size (2022 VS 2027)

List of Figures

Figure 1. Picture of COVID-19 Recombinant Protein Vaccine

Figure 2. COVID-19 Recombinant Protein Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate 2022-2028 ($ Millions)

Figure 7. COVID-19 Recombinant Protein Vaccine Market Size by Region (2022 & 2027) ($ millions)

Figure 8. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2022-2028)

Figure 9. Global Being Developed Market Size Growth Rate

Figure 10. Global Preclinical Market Size Growth Rate

Figure 11. Global Clinical I Market Size Growth Rate

Figure 12. Global Clinical II Market Size Growth Rate

Figure 13. COVID-19 Recombinant Protein Vaccine in Pharmaceutical And Biotechnology Companies

Figure 14. Global COVID-19 Recombinant Protein Vaccine Market: Pharmaceutical And Biotechnology Companies (2022-2028) ($ Millions)

Figure 15. COVID-19 Recombinant Protein Vaccine in Hospital

Figure 16. Global COVID-19 Recombinant Protein Vaccine Market: Hospital (2022-2028) ($ Millions)

Figure 17. COVID-19 Recombinant Protein Vaccine in Academic And Research Organizations

Figure 18. Global COVID-19 Recombinant Protein Vaccine Market: Academic And Research Organizations (2022-2028) ($ Millions)

Figure 19. COVID-19 Recombinant Protein Vaccine in Other

Figure 20. Global COVID-19 Recombinant Protein Vaccine Market: Other (2022-2028) ($ Millions)

Figure 21. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2022-2028)

Figure 22. Global COVID-19 Recombinant Protein Vaccine Market Size in Pharmaceutical And Biotechnology Companies Growth Rate

Figure 23. Global COVID-19 Recombinant Protein Vaccine Market Size in Hospital Growth Rate

Figure 24. Global COVID-19 Recombinant Protein Vaccine Market Size in Academic And Research Organizations Growth Rate

Figure 25. Global COVID-19 Recombinant Protein Vaccine Market Size in Other Growth Rate

Figure 26. Funding/Investment

Figure 27. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions 2022-2028

Figure 28. United States COVID-19 Recombinant Protein Vaccine Market Size 2022-2028 ($ Millions)

Figure 29. China COVID-19 Recombinant Protein Vaccine Market Size 2022-2028 ($ Millions)

Figure 30. Europe COVID-19 Recombinant Protein Vaccine Market Size 2022-2028 ($ Millions)

Figure 31. Rest of World COVID-19 Recombinant Protein Vaccine Market Size 2022-2028 ($ Millions)

Figure 32. United States COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2027

Figure 33. United States COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2027

Figure 34. China COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2027

Figure 35. China COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2027

Figure 36. Europe COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2027

Figure 37. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2027

Figure 38. Rest of World COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2027

Figure 39. Rest of World COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2027